Getagraph.com logo
NASDAQ Composite: ( -0.07%) 16 686
S&P 500
(0.12%) 5 303.27 points
Dow Jones
(0.34%) 40 004 points
Nasdaq
(-0.07%) 16 686 points
Oil
(0.97%) $80.00
Gas
(5.73%) $2.64
Gold
(1.44%) $2 419.80
Silver
(6.36%) $31.78
Platinum
(2.18%) $1 094.70
USD/EUR
(-0.02%) $0.920
USD/NOK
(-0.18%) $10.68
USD/GBP
(-0.27%) $0.787
USD/RUB
(0.19%) $91.05

Realaus laiko atnaujinimai Eton Pharmaceuticals Inc [ETON]

Birža: NASDAQ Sektorius: Healthcare Pramonė: Biotechnology
Atnaujinta17 geg. 2024 @ 23:00
25% discount on Stockinvest.us - Use code: Podcast

-0.82% $ 3.62

Live Chart Being Loaded With Signals

Commentary (17 geg. 2024 @ 23:00):
Profile picture for Eton Pharmaceuticals Inc

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia...

Stats
Šios dienos apimtis 25 959.00
Vidutinė apimtis 63 919.00
Rinkos kapitalizacija 93.00M
EPS $0 ( 2024-05-13 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -90.50
ATR14 $0.0120 (0.33%)
Insider Trading
Date Person Action Amount type
2024-02-13 Gruber James R. Buy 144 677 Stock Option (Right to buy)
2024-02-13 Adams Jennifer Mckie Buy 30 000 Stock Option (Right to buy)
2024-02-13 Brynjelsen Sean Buy 438 633 Stock Option (Right to buy)
2024-02-13 Casamento Charles J Buy 30 000 Stock Option (Right to buy)
2024-02-13 Krempa David Buy 144 677 Stock Option (Right to buy)
INSIDER POWER
56.09
Last 96 transactions
Buy: 4 266 352 | Sell: 3 981 653

Tūris Koreliacija

Ilgas: 0.18 (neutral)
Trumpas: -0.82 (strong negative)
Signal:(47.184) Neutral

Eton Pharmaceuticals Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Eton Pharmaceuticals Inc Koreliacija - Valiuta/Žaliavos

The country flag -0.12
( neutral )
The country flag 0.40
( neutral )
The country flag 0.00
( neutral )
The country flag -0.38
( neutral )
The country flag 0.00
( neutral )
The country flag -0.52
( weak negative )

Eton Pharmaceuticals Inc Finansinės ataskaitos

Annual 2023
Pajamos: $31.64M
Bruto pelnas: $21.06M (66.56 %)
EPS: $-0.0365
FY 2023
Pajamos: $31.64M
Bruto pelnas: $21.06M (66.56 %)
EPS: $-0.0365
FY 2022
Pajamos: $21.25M
Bruto pelnas: $14.32M (67.38 %)
EPS: $-0.390
FY 2021
Pajamos: $21.83M
Bruto pelnas: $19.21M (87.99 %)
EPS: $-0.0800

Financial Reports:

No articles found.

Eton Pharmaceuticals Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Eton Pharmaceuticals Inc

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.